Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell L Margolis

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
Early Intervention in Psychiatry|April 2, 2025
Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant CharacteristicsMonica E Calkins, Megan Jumper, Arielle Ered, et al.
Schizophrenia Research|March 28, 2024
Tobacco smoking and nicotine vaping in persons with first episode psychosisMelanie E Bennett, Deborah Medoff, Tovah Cowan, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Biochemical and Biophysical Research Communications|July 10, 2012
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's diseaseJi-Hyun Lee, Jong-Min Lee, Eliana Marisa Ramos, et al.
Early Intervention in Psychiatry|April 2, 2025
Connection Learning Healthcare System Hub of the Early Psychosis Intervention Network: Program and Participant CharacteristicsMonica E Calkins, Megan Jumper, Arielle Ered, et al.
Schizophrenia Research|March 28, 2024
Tobacco smoking and nicotine vaping in persons with first episode psychosisMelanie E Bennett, Deborah Medoff, Tovah Cowan, et al.
American Journal of Human Genetics|August 6, 2003
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS studyJian-Liang Li, Michael R Hayden, Elisabeth W Almqvist, et al.
BMC Medical Genetics|August 18, 2006
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS studyJian-Liang Li, Michael R Hayden, Simon C Warby, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA|July 6, 2016
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial, Samuel Frank, Claudia M Testa, et al.
Pageof 13